Inside the $250M Aussie HealthTech Fund
Dr Steve Burnell, Managing Director of Tenmile, joins Emily Casey to discuss Australia's biotech funding gap, antimicrobial resistance, pharma dealmaking and what healthtech founders need to get right.
After five years, millions of reads globally and more than 10,000 people attending events, What The Health is finally bringing its content and conversations to a podcast you can listen to on the go. Expect high-quality conversations with some of the smartest people in health innovation.
What The Health cuts through the noise in health innovation with honest conversations, practical insights and the people shaping what’s next. Less hype. More signal.
Read the What The Health newsletter for sharp takes on the health stories worth your attention. We also host events and run a private community for people shaping the future of health.
Dr Steve Burnell, Managing Director of Tenmile, joins Emily Casey to discuss Australia's biotech funding gap, antimicrobial resistance, pharma dealmaking and what healthtech founders need to get right.
8 episodes
Dr Steve Burnell, Managing Director of Tenmile, joins Emily Casey to discuss Australia's biotech funding gap, antimicrobial resistance, pharma dealmaking and what healthtech founders need to get right.
In Part Two of my conversation with Dr Steven Lu, Everlab’s co-founder and Chief Medical Officer, we unpack what’s actually worth measuring, which treatments show real promise, what’s still experimental and what the future of preventative healthcare could look like.
In Part One of this two-part conversation, I sit down with Dr Steven Lu, Everlab’s co-founder and Chief Medical Officer, to unpack how they actually built it, and what it takes to turn the promise of longevity into real-world medicine.
A personalised mRNA cancer vaccine has succeeded in a late-stage trial for the first time, and Moderna's shares ripped as much as 177% in a single day on the news. Cancer vaccines have been a graveyard for decades.
Dr Michael Winlo, Chief Scientific Officer at Emyria, on how Australia became the first country where psychiatrists can prescribe MDMA and psilocybin — and what it will take to move psychedelic-assisted therapy from last resort to mainstream care.
A survey of 1,800 clinicians across 25 countries found 83% adopted AI before their workplace had any governance. Emily Casey, Dr Simon Kos and Dr Janice Tan unpack what happens once AI scribes become table stakes.
Novartis has agreed to acquire Myricx Bio for up to US$1.5 billion, approximately A$2.2 billion. Emily Casey, Dr Jackie Rabec and Dr Prashanth Rajan unpack what it means for biotech, AI, R&D policy and preventive health.
Five years of health innovation coverage, millions of reads, and a community of 11,000+.
Try another name or topic, or return to the full archive.
Join Australia's and the world's leading minds shaping the future of health.
Learn what is actually happening beyond the headlines, what is worth paying attention to and why it matters.
Healthcare is hard, but keeping up shouldn't be. We make the signal easier to follow.
Emily Casey is the Director & Head of Community at What The Health, where she has spent five years building a global audience around health innovation through editorial, events and community.
On the podcast, she covers what is happening beyond the headlines, what is worth paying attention to and why it matters.
Smart insights. Sharp takes. Subscribe wherever you get your podcasts, or get the drop straight to your inbox and never miss a hot take.
What The Health is produced by Day One®, trusted partners in the technology space and the team that helped build Blackbird Ventures' Wild Hearts. Sister shows include First Cheque, Oversubscribed and Pick My Brain, and episodes are cross-promoted across the network.
Host-read sponsorships and campaigns across Day One® shows for Australian founders, operators and investors, from A$15,000 +GST.